Zollinger-Ellison syndrome (Q39824): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: E16.4 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 05:22, 13 August 2026
A syndrome characterised by the presence of a gastrin-secreting tumour, usually in the pancreas or duodenum, resulting in increased gastric acidity and formation of gastric ulcers. Signs and symptoms include abdominal pain and diarrhea. It may be sporadic or a manifestation of multiple endocrine neoplasia type 1.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 5A43.1 |
||
| English | Zollinger-Ellison syndrome |
A syndrome characterised by the presence of a gastrin-secreting tumour, usually in the pancreas or duodenum, resulting in increased gastric acidity and formation of gastric ulcers. Signs and symptoms include abdominal pain and diarrhea. It may be sporadic or a manifestation of multiple endocrine neoplasia type 1. |
Statements
CID11:5A43.1
0 references
dki-india-5A43.1
0 references
Concluído
0 references
13 August 2026
0 references
